Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High density lipoprotein measurement
|
1440 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.800 | 1.000 | 3 | 2011 | 2018 | |||||
Triglycerides measurement
|
1418 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.800 | 1.000 | 3 | 2011 | 2018 | |||||
Serum total cholesterol measurement
|
1243 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.800 | 1.000 | 2 | 2012 | 2018 | |||||
Metabolic Syndrome X
|
591 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||
Blood Pressure
|
220 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
Pseudocholinesterase Measurement
|
568 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Serum albumin measurement
|
3282 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Serum HDL cholesterol measurement
|
679 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
HYPERTRIGLYCERIDEMIA, SUSCEPTIBILITY TO
|
3 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.700 | 0 | ||||||||
Coronary Artery Disease
|
1577 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.020 | 1.000 | 2 | 2014 | 2018 | |||||
Angina, Unstable
|
21 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Cholangiocarcinoma
|
43 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Chronic Kidney Diseases
|
306 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Cockayne Syndrome, Type I
|
42 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Nuchal bleb, familial
|
9 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Sleep Apnea, Central
|
17 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Stable angina
|
8 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Vascular lesions
|
9 | 0.763 | 0.440 | 11 | 116789970 | 3 prime UTR variant | G/A | snv | 0.93 | 0.010 | 1.000 | 1 | 2014 | 2014 |